Impact Partnership Wealth LLC Purchases New Holdings in Docusign Inc. $DOCU

Impact Partnership Wealth LLC acquired a new stake in shares of Docusign Inc. (NASDAQ:DOCU) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 11,850 shares of the company’s stock, valued at approximately $562,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. NewEdge Advisors LLC boosted its stake in shares of Docusign by 36.4% during the 1st quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock valued at $749,000 after buying an additional 2,457 shares during the last quarter. Guggenheim Capital LLC increased its stake in shares of Docusign by 6.7% in the second quarter. Guggenheim Capital LLC now owns 11,543 shares of the company’s stock worth $899,000 after buying an additional 729 shares during the last quarter. State Street Corp raised its holdings in Docusign by 3.0% in the second quarter. State Street Corp now owns 8,074,976 shares of the company’s stock valued at $628,960,000 after acquiring an additional 236,494 shares in the last quarter. Sei Investments Co. raised its holdings in Docusign by 60.7% in the second quarter. Sei Investments Co. now owns 40,386 shares of the company’s stock valued at $3,146,000 after acquiring an additional 15,247 shares in the last quarter. Finally, Treasurer of the State of North Carolina boosted its stake in Docusign by 51.0% during the 2nd quarter. Treasurer of the State of North Carolina now owns 189,178 shares of the company’s stock valued at $14,735,000 after acquiring an additional 63,911 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Docusign Price Performance

DOCU stock opened at $46.02 on Thursday. The firm has a market cap of $8.79 billion, a price-to-earnings ratio of 29.88, a PEG ratio of 1.31 and a beta of 0.90. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The firm has a fifty day moving average price of $46.93 and a two-hundred day moving average price of $51.11.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The company had revenue of $830.24 million for the quarter, compared to the consensus estimate of $824.71 million. During the same period last year, the firm posted $0.90 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, analysts expect that Docusign Inc. will post 2.03 EPS for the current fiscal year.

Docusign announced that its board has initiated a share repurchase plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 21% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

DOCU has been the subject of several research analyst reports. BTIG Research dropped their target price on shares of Docusign from $70.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, June 5th. UBS Group set a $60.00 price target on shares of Docusign in a research report on Friday, June 5th. Morgan Stanley decreased their price target on Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research note on Wednesday, March 18th. Jefferies Financial Group boosted their price objective on Docusign from $45.00 to $50.00 and gave the company a “hold” rating in a report on Friday, June 5th. Finally, JPMorgan Chase & Co. cut their price objective on Docusign from $78.00 to $65.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $60.27.

Insider Transactions at Docusign

In other Docusign news, CRO Paula Hansen sold 6,000 shares of Docusign stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $273,240.00. Following the completion of the transaction, the executive directly owned 89,972 shares in the company, valued at $4,097,324.88. The trade was a 6.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the transaction, the insider directly owned 52,815 shares of the company’s stock, valued at $2,405,195.10. This trade represents a 18.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 76,695 shares of company stock valued at $3,476,002 over the last ninety days. Insiders own 0.59% of the company’s stock.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.